With CAR-T therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this from becoming the ‘sell-out’ therapy that the field had hoped for. The CAR-TCR Europe Summit will unravel the technical challenges across translation, scale and delivery to provide your team with the platform to learn, collaborate and gain actionable insights to advance your therapy for clinical and commercial success.

This focused agenda will delve into the technical bottlenecks encountered in every stage of the CAR-TCR drug development cycle, providing a comprehensive analysis across 3 tracks including: Translational, Manufacturing & Clinical

To learn more about CAR-TCR Europe Summit and to register online, visit https://ter.li/9iuqer